Sage Rhino Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Buy |
12,604
+919
| +8% | +$14.2K | 0.04% | 254 |
|
|
2025
Q1 | $174K | Sell |
11,685
-155
| -1% | -$2.31K | 0.04% | 242 |
|
|
2024
Q4 | $157K | Buy |
11,840
+1,538
| +15% | +$20.4K | 0.03% | 249 |
|
|
2024
Q3 | $146K | Buy |
+10,302
| New | +$146K | 0.03% | 256 |
|
|
2024
Q2 | – | Sell |
-11,787
| Closed | -$164K | – | 265 |
|
|
2024
Q1 | $164K | Buy |
+11,787
| New | +$164K | 0.04% | 215 |
|
|
2023
Q4 | – | Sell |
-11,751
| Closed | -$182K | – | 246 |
|
|
2023
Q3 | $182K | Buy |
11,751
+831
| +8% | +$12.9K | 0.05% | 199 |
|
|
2023
Q2 | $172K | Buy |
10,920
+178
| +2% | +$2.8K | 0.05% | 205 |
|
|
2023
Q1 | $177K | Buy |
+10,742
| New | +$177K | 0.05% | 202 |
|